Sienel et al(18) compared the expression of MAGE-A3 in stage I and II NSCLCs and observed that in comparison with stage I tissues, the rate of MAGE-A3-positive tumors was significantly increased in stage II tissues, which was in agreement with its possible role in tumor metastasis. Here, MAGEA3 is linked to neoplasm.